| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2023 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12204-2732 | ALBANY | USA | NU88EH001329 | Expanding New York State?s biomonitoring program for emerging and legacy contaminants | 01 | 5 | CDC | 10/4/2023 | $0 |
| | 2024 | 2023 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12204-2732 | ALBANY | USA | R01GM139277 | Systematic Discovery and Analysis of Small Proteins and Small ORFs in Mycobacteria | 000 | 4 | NIH | 11/21/2023 | $0 |
| | 2024 | 2022 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12204-2732 | ALBANY | USA | NU88EH001329 | Expanding New York State?s biomonitoring program for emerging and legacy contaminants | 01 | 5 | CDC | 10/4/2023 | $0 |
| | 2024 | 2022 | HEALTH RESEARCH, INC. | 150 BROADWAY STE 280 | MENANDS | NY | 12204-2732 | ALBANY | USA | R03AI150987 | STnc520, a virulence-associated regulatory RNA in Salmonella Typhimurium | 000 | 2 | NIH | 11/27/2023 | $0 |
| | 2024 | 2021 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12204-2732 | ALBANY | USA | NU88EH001329 | Expanding New York State?s biomonitoring program for emerging and legacy contaminants | 01 | 5 | CDC | 10/4/2023 | $0 |
| | 2024 | 2020 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12204-2732 | ALBANY | USA | NU88EH001329 | Expanding New York State?s biomonitoring program for emerging and legacy contaminants | 01 | 5 | CDC | 10/4/2023 | $0 |
| | 2024 | 2019 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12204-2732 | ALBANY | USA | NU88EH001329 | Expanding New York State?s biomonitoring program for emerging and legacy contaminants | 01 | 5 | CDC | 10/4/2023 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $10,372,331 ) (Continued on the next page) |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12204-2732 | ALBANY | USA | U01CA260508 | High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology | 002 | 2 | NIH | 6/21/2023 | $0 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | Empire State Plaza | Albany | NY | 12237-0001 | ALBANY | USA | H4N49259 | State Newborn Screening System Priorities Program | 00 | 1 | HRSA | 5/30/2023 | $145,000 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | Empire State Plaza | Albany | NY | 12237-0001 | ALBANY | USA | H4N49259 | State Newborn Screening System Priorities Program | 00 | 1 | HRSA | 5/30/2023 | $200,000 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | EMPIRE STATE PLAZA | ALBANY | NY | 12237-0001 | ALBANY | USA | R35GM144328 | Unexpected complexity in bacterial genomes | 000 | 2 | NIH | 1/5/2023 | $384,499 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | EMPIRE STATE PLAZA | ALBANY | NY | 12237-0001 | ALBANY | USA | R01GM144361 | Characterization of the mechanisms underpinning quorum sensing progression in Pseudomonas aeruginosa | 001 | 2 | NIH | 1/25/2023 | $56,076 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | EMPIRE STATE PLAZA | ALBANY | NY | 12237-0001 | ALBANY | USA | R01GM144361 | Characterization of the mechanisms underpinning quorum sensing progression in Pseudomonas aeruginosa | 000 | 2 | NIH | 1/18/2023 | $254,638 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | EMPIRE STATE PLAZA | ALBANY | NY | 12237-0001 | ALBANY | USA | R01AI168097 | Modeling the influence of temperature on the evolution of vector-virus interactions | 000 | 2 | NIH | 1/10/2023 | $484,931 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | EMPIRE STATE PLAZA | ALBANY | NY | 12237-0001 | ALBANY | USA | R35GM130298 | Efficiency and fidelity in mitotic spindle assembly | 000 | 5 | NIH | 1/26/2023 | $406,127 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12204-2732 | ALBANY | USA | U01CA260508 | High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology | 000 | 2 | NIH | 6/2/2023 | $824,595 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12204-2732 | ALBANY | USA | U01FD007143 | NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance | 000 | 4 | FDA | 8/3/2023 | $185,000 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12204-2732 | ALBANY | USA | U2CES026542 | Wadsworth Center's Human Health and Exposure Analysis Resource (WC-HHEAR) | 000 | 5 | NIH | 5/30/2023 | $729,000 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12204-2732 | ALBANY | USA | U19FD007089 | Wadsworth Center's Radiochemical, Microbiological and Chemical Testing for Food Defense and Capability Development | 005 | 4 | FDA | 7/18/2023 | $0 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12204-2732 | ALBANY | USA | U19FD007089 | Wadsworth Center's Radiochemical, Microbiological and Chemical Testing for Food Defense and Capability Development | 004 | 4 | FDA | 6/29/2023 | $926,394 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12204-2732 | ALBANY | USA | R01AI110112 | Latitudinal Landscape Genomics and Ecology of Anopheles Darlingi | 000 | 9 | NIH | 8/22/2023 | $401,519 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12204-2732 | ALBANY | USA | R01AI155473 | Role of ribosome modulating proteins in conferring Mycobacterium abscessus antibiotic resistance | 000 | 4 | NIH | 8/1/2023 | $478,217 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12204-2732 | ALBANY | USA | R01GM139277 | Systematic Discovery and Analysis of Small Proteins and Small ORFs in Mycobacteria | 000 | 4 | NIH | 8/25/2023 | $546,967 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12204-2732 | ALBANY | USA | NU88EH001329 | Expanding New York State?s biomonitoring program for emerging and legacy contaminants | 00 | 5 | CDC | 6/27/2023 | $900,060 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12204-2732 | ALBANY | USA | R35GM130298 | Efficiency and fidelity in mitotic spindle assembly | 001 | 5 | NIH | 3/31/2023 | $45,126 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12204-2732 | ALBANY | USA | H4N49259 | State Newborn Screening System Priorities Program | 01 | 1 | HRSA | 6/28/2023 | $0 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12204-2732 | ALBANY | USA | H4N49259 | State Newborn Screening System Priorities Program | 01 | 1 | HRSA | 6/28/2023 | $0 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12204-2732 | ALBANY | USA | R56AI168356 | RNA regulation associated with mcr11-abmR locus in M. tuberculosis | 000 | 1 | NIH | 7/31/2023 | $565,149 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12204-2732 | ALBANY | USA | R01GM144372 | Dissecting and connecting the SigM stimulus and ESX-4 secretory response in mycobacteria | 000 | 2 | NIH | 9/8/2023 | $405,318 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12204-2732 | ALBANY | USA | R35GM144328 | Unexpected complexity in bacterial genomes | 001 | 2 | NIH | 3/23/2023 | $42,721 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12204-2732 | ALBANY | USA | R01GM144361 | Characterization of the mechanisms underpinning quorum sensing progression in Pseudomonas aeruginosa | 003 | 2 | NIH | 6/6/2023 | $154,453 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12204-2732 | ALBANY | USA | R01AI132422 | Alternative Ribosomes & Antibiotic Tolerance in Mycobacteria | 002 | 6 | NIH | 9/20/2023 | $440,628 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12204-2732 | ALBANY | USA | R01GM144361 | Characterization of the mechanisms underpinning quorum sensing progression in Pseudomonas aeruginosa | 002 | 2 | NIH | 3/28/2023 | $28,293 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12204-2732 | ALBANY | USA | R01GM143223 | Intraflagellar transport process in primary cilium maintenance | 002 | 3 | NIH | 8/22/2023 | $79,816 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12204-2732 | ALBANY | USA | R01GM143223 | Intraflagellar transport process in primary cilium maintenance | 001 | 3 | NIH | 6/22/2023 | $349,043 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12204-2732 | ALBANY | USA | U2CES026542 | Wadsworth Center's Human Health and Exposure Analysis Resource (WC-HHEAR) | 001 | 5 | NIH | 8/8/2023 | $946,826 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12204-2732 | ALBANY | USA | R01GM143223 | Intraflagellar transport process in primary cilium maintenance | 000 | 2 | NIH | 5/2/2023 | $11,134 |
| | 2023 | 2023 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12204-2732 | ALBANY | USA | U2CES026542 | Wadsworth Center's Human Health and Exposure Analysis Resource (WC-HHEAR) | 000 | 5 | NIH | 5/30/2023 | $759,318 |
| | 2023 | 2022 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12237-2732 | | USA | U1W42317 | Long-term Follow-up for SCID and other NBS Conditions | 02 | 2 | HRSA | 10/22/2022 | $0 |
| | 2023 | 2022 | HEALTH RESEARCH, INC. | EMPIRE STATE PLAZA | ALBANY | NY | 12237-0001 | ALBANY | USA | U19FD007089 | Wadsworth Center's Radiochemical, Microbiological and Chemical Testing for Food Defense and Capability Development | 000 | 3 | FDA | 12/27/2022 | $0 |
| | 2023 | 2022 | HEALTH RESEARCH, INC. | EMPIRE STATE PLAZA | ALBANY | NY | 12237-0001 | ALBANY | USA | U19FD007089 | Wadsworth Center's Radiochemical, Microbiological and Chemical Testing for Food Defense and Capability Development | 001 | 3 | FDA | 2/28/2023 | $0 |
| | 2023 | 2022 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12204-2732 | ALBANY | USA | U01CA260508 | High-Throughput Dried Blood Spot (HT-DBS) Technologies in SARS COV-2 Serology and Vaccinology | 001 | 2 | NIH | 6/21/2023 | $0 |
| | 2023 | 2022 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12204-2732 | ALBANY | USA | U19FD007089 | Wadsworth Center's Radiochemical, Microbiological and Chemical Testing for Food Defense and Capability Development | 002 | 3 | FDA | 3/21/2023 | $0 |
| | 2023 | 2022 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12204-2732 | ALBANY | USA | U19FD007089 | Wadsworth Center's Radiochemical, Microbiological and Chemical Testing for Food Defense and Capability Development | 003 | 3 | FDA | 5/8/2023 | $0 |
| | 2023 | 2022 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12204-2732 | ALBANY | USA | NU88EH001329 | Expanding New York State?s biomonitoring program for emerging and legacy contaminants | 00 | 5 | CDC | 6/27/2023 | $0 |
| | 2023 | 2022 | HEALTH RESEARCH, INC. | STE 280, RIVERVIEW CENTER | MENANDS | NY | 12204-2732 | ALBANY | USA | U1W42317 | Long-term Follow-up for SCID and other NBS Conditions | 03 | 2 | HRSA | 7/17/2023 | $0 |
| | 2023 | 2021 | HEALTH RESEARCH, INC. | EMPIRE STATE PLAZA | ALBANY | NY | 12237-0001 | ALBANY | USA | R21AI149278 | Microbial genetic variation in the pathogenesis of Lyme Disease | 000 | 2 | NIH | 11/9/2022 | $0 |
| | 2023 | 2021 | HEALTH RESEARCH, INC. | EMPIRE STATE PLAZA | ALBANY | NY | 12237-0001 | ALBANY | USA | R21AI149278 | Microbial genetic variation in the pathogenesis of Lyme Disease | 001 | 2 | NIH | 1/20/2023 | $0 |
|
